文献速递头颈外科

顺铂偶联金纳米颗粒作为头颈癌诊疗一体化制剂

Cisplatin-conjugated gold nanoparticles as a theranostic agent for head and neck cancer.
PubMed 文献 · Head Neck · 2017-11-11

本研究开发了一种同时作为放射增敏剂、药物载体和肿瘤显像剂的纳米平台,即葡萄糖和顺铂包覆的20 nm金纳米颗粒(CG-GNPs)。体外实验显示CG-GNPs可高效穿透肿瘤细胞,细胞毒性与游离顺铂相似;体内实验表明CG-GNPs联合放疗的肿瘤缩小效果优于单纯放疗和放疗联合游离顺铂,并具备高效肿瘤显像能力。

要点

  • CG-GNPs兼具放射增敏、药物递送和肿瘤显像三重功能。
  • CG-GNPs联合放疗的抑瘤效果优于单纯放疗及放疗联合游离顺铂。
  • CG-GNPs的体外细胞毒性与游离顺铂相似。

核心结论

  • CG-GNPs具有增强抗肿瘤效应、克服化疗和放疗耐药以及实现显像引导治疗的潜力。

研究设计与样本

  • 合成20 nm金纳米颗粒,表面包覆葡萄糖和顺铂(CG-GNPs),进行体外细胞摄取与毒性评价及体内抑瘤与显像实验。

主要发现

  • CG-GNPs可高效穿透肿瘤细胞,细胞毒性与游离顺铂相似。
  • CG-GNPs联合放疗的肿瘤缩小程度大于单纯放疗和放疗联合游离顺铂。
  • CG-GNPs表现出高效的肿瘤显像能力。

临床怎么用

  • CG-GNPs有望作为头颈癌诊疗一体化纳米平台,实现放疗增敏、化疗递送与显像引导治疗相结合。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The purpose of this study was to develop a nanoplatform, which simultaneously acts as radiosensitizer, drug carrier, and tumor imaging agent for head and neck cancer. METHODS: We synthesized 20 nm gold nanoparticles, coated with glucose and cisplatin (CG-GNPs). Their penetration into tumor cells and their cellular toxicity were evaluated in vitro. In vivo experiments were conducted to evaluate their impact on tumor growth and their imaging capabilities. RESULTS: The CG-GNPs showed efficient penetration into tumor cells and similar cellular toxicity as cisplatin alone. Combined with radiation, CG-GNPs led to greater tumor reduction than that of radiation alone and radiation with free cisplatin. The CG-GNPs also demonstrated efficient tumor imaging capabilities. CONCLUSION: Our CG-GNPs have a great potential to increase antitumor effect, overcome resistance to chemotherapeutics and radiation, and allow imaging-guided therapy.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Davidi ES, Dreifuss T, Motiei M, et al. Cisplatin-conjugated gold nanoparticles as a theranostic agent for head and neck cancer. Head Neck. 2017. PMID: 29130566. doi:10.1002/hed.24935

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。